The Evolving Role of Nonsteroidal Topicals in Inflammatory Dermatoses

This episode, titled “The Evolving Role of Nonsteroidal Topicals in Inflammatory Dermatoses,” features panelists discussing the efficacy of advanced targeted topical therapies and their growing role in the long-term management of inflammatory skin diseases. Building on previous discussions of safety and tolerability, the expert faculty review evidence supporting both the short-term and long-term effectiveness of nonsteroidal topical treatments across multiple inflammatory dermatoses.

The panel examines clinical trial data demonstrating meaningful improvements in disease severity, skin clearance, and symptom control with newer targeted topical therapies. Faculty members highlight how these agents have challenged traditional assumptions about the efficacy of nonsteroidal treatments, with several therapies demonstrating levels of effectiveness that were previously difficult to achieve without corticosteroids. The discussion also explores long-term outcomes, including durable disease control, flare prevention, and extended periods of treatment-free maintenance.

A key theme throughout the conversation is the shift from reactive flare management to proactive disease control. The panel discusses how treatment success is increasingly being defined not only by short-term improvement, but also by durability of response, reduction in treatment burden, and the ability to maintain control with fewer interventions over time. Expert faculty emphasize the important role that advanced nonsteroidal topicals can play in maintenance strategies, helping patients achieve longer periods of stability while reducing reliance on corticosteroids. The discussion concludes with an examination of barriers to broader adoption, including established prescribing habits, perceived access challenges, and administrative considerations. Despite these hurdles, the panel highlights the growing confidence clinicians have in incorporating nonsteroidal topicals earlier in treatment algorithms for inflammatory dermatoses.

Our next episode, “Improving Access to Advanced Nonsteroidal Topical Therapies in Inflammatory Dermatoses,” concludes the series by highlighting practical strategies to overcome access barriers and incorporate advanced nonsteroidal topical therapies into clinical practice. The panelists summarize key consensus recommendations and discuss how these therapies can help support long-term disease control while reducing reliance on chronic corticosteroid use.